Cipla Limited (NSE:CIPLA)
India · Delayed Price · Currency is INR 1,224.20
-18.10 (-1.46%)
At close: Mar 30, 2026
Cipla Market Cap
Cipla has a market cap or net worth of 1 trillion as of March 30, 2026. Its market cap has decreased by -15.00% in one year.
Market Cap
1.00T
Enterprise Value
903.22B
Revenue
279.67B
Ranking
n/a
PE Ratio
22.09
Stock Price
1,224.20
Market Cap Chart
Since May 30, 1996, Cipla's market cap has increased from 1.51B to 1.00T, an increase of 66,194.81%. That is a compound annual growth rate of 24.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 1.00T | -17.80% |
| Dec 31, 2025 | 1.22T | -1.14% |
| Dec 31, 2024 | 1.23T | 22.72% |
| Dec 29, 2023 | 1.01T | 15.87% |
| Dec 30, 2022 | 868.37B | 14.01% |
| Dec 31, 2021 | 761.69B | 15.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Divi's Laboratories | 1.59T |
| Zydus Lifesciences | 902.29B |
| Mankind Pharma | 841.67B |
| Aurobindo Pharma | 763.29B |
| Alkem Laboratories | 639.02B |
| Glenmark Pharmaceuticals | 612.52B |
| Laurus Labs | 544.61B |
| Ipca Laboratories | 402.37B |